Stockreport

Inozyme Pharma Reports First Quarter 2024 Financial Results and Provides Business Highlights [Yahoo! Finance]

Inozyme Pharma, Inc.  (INZY) 
PDF - Interim data from ENERGY-1, a Phase 1b trial of INZ-701 in infants with ENPP1 Deficiency, on track for second half of 2024 - - Cash, cash equivalents, and short-ter [Read more]